UNSPSC 51451613: Oxfendazole sulfone

This classification denotes an antihelminthic agent with the molecular formula C15H13N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FQM8UA6SPQ, chemically known as carbamic acid, n-(6-(phenylsulfonyl)-1h-benzimidazol-2-yl)-, methyl ester, but more generally known as oxfendazole sulfone, which bears US NIH Compound Identifier 162136. European Medicines Agency schedules oxfendazole sulfone or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09519MIG.

Most nations, for tariff purposes, schedule oxfendazole sulfone under HS 29339990. SMILES: COC(=O)NC1[NH]C2CCC(CC2N1)S(=O)(=O)C3CCCCC3.

UNSPSC 51451613 Oxfendazole sulfone is a Commodity code that captures pharmaceutical active ingredients and formulated drugs procured by state and local health agencies for public health programs and emergency response. Recent state and local opportunities under this code show activity in antibiotic and naloxone procurement—agents used in emergency preparedness, disease control, and overdose response. The issuing bodies are state departments of public health and county health authorities. Scope of work includes supply contracts for pharmaceutical warehouse orders through cooperative purchasing consortia such as MMCAP Infuse, as well as direct procurement of specific pharmaceutical products with defined packaging, expiration windows, and delivery schedules. Contracts typically carry initial terms of one to two years with renewal options and include requirements for drug-free workplace certification, E-Verify compliance, and proof of legal authorization to work in the United States.

Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, with a total award amount of $2,999,999.11 over the life of the contract including renewals and an initial 12-month term. Seminole County, Florida issued an IFB in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the contract carries a two-year initial term with a one-year renewal option. Recent activity centers on Florida and Illinois, with procurement flowing through established cooperative purchasing vehicles and county health departments.